考比替尼是一种激酶抑制剂,其适应症为: • 与维莫非尼联合用于治疗携带 BRAF V600E 或 V600K 突变的不可切除或转移性黑色素瘤成年患者。 • 作为单药用于治疗组织细胞肿瘤成年患者。
相关产品
¥1,500.00
≈ ₭4,575,000
≈ ₭4,575,000
0 out of 5
¥1,365.00
≈ ₭4,163,250
≈ ₭4,163,250
0 out of 5
¥2,015.00
≈ ₭6,145,750
≈ ₭6,145,750
0 out of 5
¥1,500.00
≈ ₭4,575,000
≈ ₭4,575,000
0 out of 5
¥750.00
≈ ₭2,287,500
≈ ₭2,287,500
0 out of 5
¥1,350.00
≈ ₭4,117,500
≈ ₭4,117,500
0 out of 5
¥2,150.00
≈ ₭6,557,500
≈ ₭6,557,500
0 out of 5
¥195.00
≈ ₭594,750
≈ ₭594,750
0 out of 5














评价
目前还没有评价